Gadolinium-primarily based distinction brokers (GBCAs) are widely used in magnetic resonance imaging (MRI) to enhance the visibility of blood vessels, tumors, inflammation, together with other interior buildings. Though generally regarded as Protected, considerations about GBCA toxicity have emerged over the past two decades—particularly in patie